Remove Arrhythmia Remove Cardiomyopathy Remove Tachycardia
article thumbnail

Risk of Atrial Arrhythmias in Patients with Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy

HeartRhythm

In arrhythmogenic right ventricular cardiomyopathy (ARVC), risk of atrial arrhythmias (AA) persists after ventricular tachycardia (VT) ablation.

article thumbnail

PO-05-043 VENTRICULAR TACHYCARDIA AS AN EARLY MANIFESTATION OF A HERITABLE CARDIOMYOPATHY: THE EVOLVING SCOPE OF GENETIC PANELS IN THE WORKUP OF VENTRICULAR ARRHYTHMIAS

HeartRhythm

Decisions as to the scope of workup for pathologic cardiac substrates in patients with ventricular arrhythmias can be challenging. Recent data suggests that in this scenario, disease specific genetic arrhythmia panels may miss heritable diagnoses over arrhythmic plus cardiomyopathy panels.(1)

article thumbnail

Arrhythmias in children undergoing orthotopic heart transplantation

Frontiers in Cardiovascular Medicine

Introduction Heart transplantation (HT) is the only treatment option in children with heart failure secondary to cardiomyopathies and non-reparable congenital heart diseases. 24 patients (88.8%) were diagnosed with dilated cardiomyopathy, 2 (7.4%) with restrictive cardiomyopathy, and 1 (3.7%) with hypertrophic cardiomyopathy.

article thumbnail

Cardiac magnetic resonance for ventricular arrhythmias: a systematic review and meta-analysis

Heart BMJ

Background Cardiac magnetic resonance (CMR) allows comprehensive myocardial tissue characterisation, revealing areas of myocardial inflammation or fibrosis that may predispose to ventricular arrhythmias (VAs). A change in diagnosis after use of CMR ranged from 21% to 66% with a pooled average of 35% (29%–41%). to 2.42).

article thumbnail

Case Report: Multiple types of arrhythmias in a late-confirmed Danon disease

Frontiers in Cardiovascular Medicine

Introduction Danon disease is an X-linked disorder caused by pathogenic variants in lysosome-associated membrane protein 2 ( LAMP2 ) gene, typically characterized by the triad of hypertrophic cardiomyopathy, myopathy, and intellectual disability. However, many patients may not present the typical presentation, especially in the early stage.

article thumbnail

PO-05-111 CLINICAL OUTCOMES OF CATHETER ABLATION FOR ATRIAL FIBRILLATION, ATRIAL FLUTTER, AND ATRIAL TACHYCARDIA IN WILD-TYPE TRANSTHYRETIN AMYLOID CARDIOMYOPATHY: A PROPOSED TREATMENT STRATEGY FOR CATHETER ABLATION IN EACH ARRHYTHMIA

HeartRhythm

Wild-type transthyretin amyloid cardiomyopathy (ATTRwt-CM) is often accompanied by atrial fibrillation (AF), atrial flutter (AFL), and atrial tachycardia (AT), which are difficult to control because beta-blockers and antiarrhythmic drugs can worsen heart failure (HF).

article thumbnail

MP-470552-006 BELHASSEN'S VENTRICULAR TACHYCARDIA: A CASE OF AN INFANT REQUIRING MORE THAN JUST VERAPAMIL

HeartRhythm

Belhassen’s ventricular tachycardia is an uncommon arrhythmia in infants. Originating near the left posterior fascicle, it is initiated by supraventricular ectopy or sinus tachycardia and is uniquely sensitive to verapamil. Use of verapamil in infants is controversial due to risk of severe hemodynamic compromise.